Vitamin C Targets Same Enzyme as New Anti-Covid Drugs
Posted: Thu Dec 16, 2021 8:15 am
Vitamin C inhibits Angiotensin-Converting Enzyme-2 in Isolated Rat Aortic Ring
https://www.docwirenews.com/abstracts/vitamin-c-inhibits-angiotensin-converting-enzyme-2-in-isolated-rat-aortic-ring/
https://www.docwirenews.com/abstracts/vitamin-c-inhibits-angiotensin-converting-enzyme-2-in-isolated-rat-aortic-ring/
RESULTS: The results confirmed that diminazene-induced vasorelaxation in a dose-dependent manner. More interestingly, ascorbic acid inhibited diminazene-induced vasorelaxation in a dose-dependent manner.
CONCLUSION: This investigation provides valuable experimental proof of the efficacy of ascorbic acid (Vitamin C) on inhibiting ex vivo vascular angiotensin-converting enzyme II, which is known among the pharmacological targets of anti-Covid-19 drugs.